Abstract
The treatment of tuberculosis is based on combinations of drugs that directly target Mycobacterium tuberculosis. A new global initiative is now focusing on a complementary approach of developing adjunct host-directed therapies.
| Original language | English |
|---|---|
| Pages (from-to) | 511-2 |
| Number of pages | 2 |
| Journal | Nature reviews. Drug discovery |
| Volume | 14 |
| Issue number | 8 |
| DOIs |
|
| Publication status | Published - 17 Jul 2015 |
Keywords
- Antitubercular Agents
- Drug Design
- Drug Therapy, Combination
- Humans
- Molecular Targeted Therapy
- Mycobacterium tuberculosis
- Tuberculosis
- Journal Article